Home/Filings/4/0001104659-21-136407
4//SEC Filing

Moss Gregory S. 4

Accession 0001104659-21-136407

CIK 0001557142other

Filed

Nov 8, 7:00 PM ET

Accepted

Nov 9, 5:39 PM ET

Size

20.6 KB

Accession

0001104659-21-136407

Insider Transaction Report

Form 4
Period: 2021-11-09
Moss Gregory S.
EVP, General Counsel
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2021-11-09$5.16/sh360,000$1,857,6000 total
    Exercise: $4.34Exp: 2030-01-27Common Stock, par value $0.001 (360,000 underlying)
  • Disposition to Issuer

    Stock Appreciation Right

    2021-11-09$4.84/sh75,000$363,0000 total
    Exercise: $4.66Exp: 2026-12-15Common Stock, par value $0.001 (75,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2021-11-09$7.03/sh75,000$527,2500 total
    Exercise: $2.47Exp: 2028-12-14Common Stock, par value $0.001 (75,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2021-11-09$7.36/sh300,000$2,208,0000 total
    Exercise: $2.14Exp: 2029-08-30Common Stock, par value $0.001 (300,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2021-11-09$5.54/sh680,000$3,767,2000 total
    Exercise: $3.96Exp: 2031-01-08Common Stock, par value $0.001 (680,000 underlying)
  • Disposition to Issuer

    Common Stock

    2021-11-09$9.50/sh17,671$167,8750 total
  • Disposition to Issuer

    Performance Stock Option (right to buy)

    2021-11-09$5.86/sh150,000$879,0000 total
    Exercise: $3.64Exp: 2027-12-08Common Stock, par value $0.001 (150,000 underlying)
  • Disposition to Issuer

    Equity Appreciation Rights Unit

    2021-11-09$3.50/sh200$7000 total
    Exercise: $6.00Exp: 2024-12-31Common Stock, par value $0.001 (200 underlying)
Footnotes (3)
  • [F1]Disposed pursuant to the acquisition by Sanofi of the entire issued share capital of Issuer on November 9, 2021 by means of a plan of merger (the "Merger").
  • [F2]In connection with the Merger, all unvested stock options ("Options") and equity appreciation rights ("EARs") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option and EAR award.
  • [F3]Represents the payment per share of Common Stock received in exchange for the cancellation of each Option and EAR.

Issuer

Kadmon Holdings, Inc.

CIK 0001557142

Entity typeother

Related Parties

1
  • filerCIK 0001742496

Filing Metadata

Form type
4
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 5:39 PM ET
Size
20.6 KB